Ajanta Pharma — 360° view

Ajanta Pharma, a company in the Pharmaceuticals industry, reported revenue of ₹1,794 crore and net profit of ₹388 crore for the September 2026 quarter.

Ajanta Pharma (NSE: AJANTPHARM) closed at ₹3,317.70 on 20 Nov 2026, up 32.1% over the past year. Its market capitalisation is ₹41,458 crore and it trades at 32.8 times earnings.

Share price
₹3,317.70 (20 Nov 2026)
Market cap
₹41,458 Cr (20 Nov 2026)
P/E
32.83 (20 Nov 2026)
Revenue
₹1,794 Cr (September 2026 quarter)
Net profit
₹388 Cr (September 2026 quarter)
ROCE
34.5% (FY26)
ROE
27.1% (FY26)
Book value
₹389 (FY26)
Dividend yield
0.96% (last 12 months to 20 Nov 2026)
52-week high / low
₹3,796.00 / ₹2,465.00 (20 Nov 2026)
1-year return
32.1% (to 20 Nov 2026)
Sector
Healthcare
Industry
Pharmaceuticals
Symbol
NSE: AJANTPHARM

Ajanta Pharma is primarily engaged in development, manufacturing and marketing of speciality pharmaceutical quality finished dosages.(Source : 202003-01 Annual Report Page No:70).

Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.